Middle East and Africa Synthetic Biology Market to 2028 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East and Africa Synthetic Biology Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East and Africa Synthetic Biology Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Investments in Synthetic Biology owing to various start-ups offer solutions for difficult microbial systems

5.2 Market Opportunities

5.2.1 Collaboration between companies so they can collaborate inter-disciplinary globally between synthetic biologists, policymakers, researchers, and industry

5.3 Future Trends

5.3.1 Rising Number of Start-Ups

5.4 Impact of Drivers and Restraints

6. Middle East and Africa Synthetic Biology Market Regional Analysis

6.1 Middle East and Africa Synthetic Biology Market Overview

6.2 Middle East and Africa Synthetic Biology Market Revenue 2019-2028 (US$ Million)

6.3 Middle East and Africa Synthetic Biology Market Forecast Analysis

7. Middle East and Africa Synthetic Biology Market Analysis – by Products

7.1 Enzymes

7.1.1 Overview
7.1.2 Enzymes: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Chassis Organisms

7.2.1 Overview
7.2.2 Chassis Organisms: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Oligonucleotides

7.3.1 Overview
7.3.2 Oligonucleotides: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Xeno-Nucleic Acids

7.4.1 Overview
7.4.2 Xeno-Nucleic Acids: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Synthetic Biology Market Analysis – by Technology

8.1 Measurement & Modeling

8.1.1 Overview
8.1.2 Measurement & Modeling: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Cloning & Sequencing

8.2.1 Overview
8.2.2 Cloning & Sequencing: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Genome Engineering

8.3.1 Overview
8.3.2 Genome Engineering: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Gene Synthesis

8.4.1 Overview
8.4.2 Gene Synthesis: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Nanotechnology

8.5.1 Overview
8.5.2 Nanotechnology: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East and Africa Synthetic Biology Market Analysis – by Application

9.1 Medical Applications

9.1.1 Overview
9.1.2 Nanotechnology: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Industrial Applications

9.2.1 Overview
9.2.2 Nanotechnology: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Food and Agriculture

9.3.1 Overview
9.3.2 Nanotechnology: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Environmental Applications

9.4.1 Overview
9.4.2 Nanotechnology: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East and Africa Synthetic Biology Market – Middle East and Africa Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa Synthetic Biology Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Middle East and Africa Synthetic Biology Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 South Africa: Middle East and Africa Synthetic Biology Market Breakdown, by Products
10.1.1.1.2 South Africa: Middle East and Africa Synthetic Biology Market Breakdown, by Technology
10.1.1.1.3 South Africa: Middle East and Africa Synthetic Biology Market Breakdown, by Application

10.1.1.2 Saudi Arabia: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East and Africa Synthetic Biology Market Breakdown, by Products
10.1.1.2.2 Saudi Arabia: Middle East and Africa Synthetic Biology Market Breakdown, by Technology
10.1.1.2.3 Saudi Arabia: Middle East and Africa Synthetic Biology Market Breakdown, by Application

10.1.1.3 UAE: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 UAE: Middle East and Africa Synthetic Biology Market Breakdown, by Products
10.1.1.3.2 UAE: Middle East and Africa Synthetic Biology Market Breakdown, by Technology
10.1.1.3.3 UAE: Middle East and Africa Synthetic Biology Market Breakdown, by Application

10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Synthetic Biology Market Breakdown, by Products
10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Synthetic Biology Market Breakdown, by Technology
10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Synthetic Biology Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East and Africa Synthetic Biology Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Amyris

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Codexis

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Genscript Biotech corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Integrated DNA Technologies

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 New England Biolabs

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Novozymes A/S

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Thermo Fisher Scientific

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Twist Bioscience

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights